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Bladder cancer is the most common urological cancer, and is the
seventh most common cancer among men, accounting for approx-
imately 200 000 new cases per year worldwide (Parkin et al,
1999). Over the last four decades, many epidemiologic studies and
several reviews have been conducted to investigate determinants
of bladder cancer (Johansson and Cohen, 1997; Ross et al, 1996;
Silverman et al, 1992; van der Meijden, 1998; World Cancer
Research Fund & American Institute for Cancer Research, 1997).
These studies suggested that bladder cancer is influenced by
environmental factors, including cigarette smoking, fluid
consumption, schistosomal infections, exposure to industrial
chemicals (e.g. aromatic amines) and diet. 
Among the dietary factors, it has been suggested that vegetable
and fruit consumption may protect against cancer at various
anatomical sites. With respect to bladder cancer, most epidemio-
logical studies support a possible protective effect of vegetable
(Bruemmer et al, 1996; D’Avanzo et al, 1995; Michaud et al,
1999; Mills et al, 1991; Negri et al, 1991) and fruit consumption
(Bruemmer et al, 1996; Chyou et al, 1993; Negri et al, 1991;
Shibata et al, 1992), although some studies have reported no asso-
ciation for vegetable (Riboli et al, 1991; Shibata et al, 1992) or
fruit consumption (Michaud et al, 1999; Riboli et al, 1991). There
are many candidate agents in fruits and vegetables that influence
bladder cancer risk, including carotenoids, vitamin C, vitamin E,
and folate. 
In the present prospective study, we were able to explore the
influence of the intake of different vitamins (i.e. retinol, vitamin C,
vitamin E, and folate), and the use of vitamin-containing supple-
ments on bladder cancer risk with substantially more cases than in
previous studies. Furthermore, with the use of a recently devel-
oped food composition table on carotenoids in Dutch foods
(1986), analyses were performed with α -carotene,  β -carotene,
lutein plus zeaxanthin, β -cryptoxanthin, and lycopene. 
MATERIALS AND METHODS 
Cohort 
The study design has been described in detail previously (van den
Brandt et al, 1990a). The cohort includes 58 279 men and 62 573
women aged 55–69 years at baseline (1986). The study population
originated from 204 municipal population registries throughout
the country. The case cohort approach was used for data
processing and analysis (Prentice, 1986). Following this approach,
a subcohort of 3500 subjects (1688 men, 1812 women) was
randomly sampled from the cohort after baseline exposure
measurement. The subcohort has been followed up for vital status
information. No subcohort members were lost to follow-up. 
Follow-up 
Follow-up for incident cancer was established by record linkage to
cancer registries and the Dutch national database of pathology
reports (van den Brandt et al, 1990b). The completeness of cancer
follow-up was estimated to be over 95% (Goldbohm et al, 1994b).
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BJOC 01-1968 977-983  1/10/01  11:52 am  Page 977of follow-up. After excluding prevalent cases with cancer other
than skin cancer a total of 3346 subcohort members (1630 men
and 1716 women) and 619 incident cases (532 men and 87
women) with microscopically confirmed, incident carcinomas of
the urinary bladder, ureters, renal pelvis or urethra were identified.
Of these cases, 584 (94.3%) were diagnosed with bladder cancer
of which 559 (95.7%) were transitional cell carcinomas. Because
the overwhelming majority of tumours occurred in the urinary
bladder and the ureters, renal pelvis, and urethra are covered by the
same urothelium as the urinary bladder, the term bladder cancer is
used as a synonym for these neoplasms. 
Exposure status 
At baseline, the cohort members completed a mailed, self-admin-
istered questionnaire on risk factors for cancer. Usual consumption
of food and beverages during the year preceding the start of the
study was assessed with a 150-item semiquantitative food
frequency questionnaire. The questionnaire was validated against
a 9-day diet record. The energy and sex-adjusted Pearson correla-
tion coefficients between the 9-day record and the questionnaire
were 0.48 for total vitamin A and 0.55 for vitamin C (Goldbohm 
et al, 1994a). The questionnaire data were key entered twice and
processed in a standardized manner blinded with respect to
case/subcohort status in order to minimize observer bias in coding
and interpretation of the data. In this study, variables of principle
interest were retinol, vitamins C and E, folate, several carotenoids
and the use of vitamin-containing supplements. The mean daily
intake of retinol, vitamins C and E were calculated using the
computerized Dutch Food Composition Table (1986). Folate data
were derived from a validated liquid chromatography trienzyme
method with which the most important Dutch foods contributing
to folate intake were analysed (Konings, 1999). For calculating the
intake of specific carotenoids an additional food composition table
has been constructed recently (Goldbohm et al, 1998). Briefly,
regularly eaten vegetables were comprehensively sampled and
analysed for their carotenoid content and the database was
completed with data from the recent literature and information
from food manufacturers (Goldbohm et al, 1998). With this
carotenoid table, we were able to evaluate six of the most impor-
tant types of carotenoids: α -carotene, β -carotene, lutein, zeaxan-
thin,  β -cryptoxanthin and lycopene. In the carotenoid food
composition table, lutein and zeaxanthin were combined, because
most literature sources had not distinguished these two
carotenoids. Most vegetables, however, contain primarily lutein
and only minor amounts of zeaxanthin. Information on dietary
supplement use was collected using an open-ended question with
space for adding a maximum of four different supplements.
Participants were asked whether they used vitamin tablets, drops
or other preparations during five years before baseline. Subjects
were categorized in users or non-users of supplements containing
vitamin A, C or E. 
Statistical analyses 
Subjects with incomplete or inconsistent dietary data were
excluded leaving 569 cases (491 men and 78 women) with bladder
cancer and 3123 subcohort members (1525 men and 1598 women)
for the analyses. 
Incidence rate ratios (RR) and corresponding 95% confidence
intervals (CI) for bladder cancer were estimated using exponentially
distributed failure time regression models (Volovics and van 
den Brandt, 1997) with the Stata statistical software package
(StataCorp, 1999) in which was accounted for additional variance
introduced by sampling from the cohort (Barlow, 1994; Lin and
Ying, 1993). 
Subjects were classified by quintile of intake of the vitamins
and carotenoids or were classified by their use of vitamin-
containing supplements (yes/no). For vitamin C, quintiles 2 and 3
and quintiles 4 and 5 were combined, because the validation study
demonstrated that these quintiles could not be distinguished
(Goldbohm et al, 1994a). Tests for trends in risk for bladder cancer
over multiple categories were assessed by fitting ordinal exposure
variables as continuous terms and performing likelihood-ratio tests
between regression models with and without these variables. 
The following variables were subsequently considered as poten-
tial confounders based on earlier analyses (Steinmaus et al, 2000;
Zeegers et al, 1999; 2000a; 2000b): consumption of alcohol
(g/day), coffee (ml/day), tea (ml/day) water (ml/day), vegetables
(g/day) and fruits (g/day), current cigarette smoking (yes/no),
smoking amount (cigarettes/day), smoking duration (years of ciga-
rette smoking), occupational exposure to dye, rubber, leather or
vehicle fumes (ever/never), and first degree family history of
bladder cancer (yes/no). Those variables that showed a more than
10% influence on the risk of bladder cancer in a multivariable
model were included as covariates in the analyses. For β -crypthox-
anthin intake, subgroup analyses were performed after stratifica-
tion by tumour morphology and invasiveness using list wise
deletion of missing data. 
RESULTS 
Table 1 presents the distribution of the dietary and supplemental
vitamin intakes and the distribution of potential confounding
factors among bladder cancer cases and sub-cohort members. The
dietary intakes of retinol, vitamin E, folate, α -carotene,  β -
carotene, lycopene, β -cryptoxanthin, and lutein/zeaxantine were
comparable between cases and sub-cohort members. The intake of
vitamin C and the use of supplements containing vitamin A, C or E
were higher among sub-cohort members than among cases. Of the
potential confounders, the distribution of age, total water, alcohol,
coffee, tea, total vegetable, and total fruit consumption was similar
for cases and sub-cohort members. More than 80% of the cases
were male, whereas in the sub-cohort approximately 50% were
male. Cigarette use was more often reported in cases than in sub-
cohort members and smoking cases appeared to smoke more ciga-
rettes per day for more years than smoking sub-cohort members.
Less than 2% of the cases and sub-cohort members reported a
family history of bladder cancer or had ever worked in a high-risk
occupation (Table 1). 
The association between vitamin and carotenoid intake and
bladder cancer risk was similar in men and women for all vitamins
and carotenoids (data not shown). Therefore, the results are
presented for men and women combined. As is shown in Table 2,
except for vitamin C intake, none of the vitamins (retinol, vitamin
E, and folate), appeared to be associated with bladder cancer risk.
The age-and sex-adjusted RRs of bladder cancer for quintiles 2
and 3 combined and quintiles 4 and 5 combined of vitamin C
intake were 0.77 (CI: 0.61–0.98) and 0.74 (CI: 0.58–0.95)
compared to the lowest quintile of intake, respectively (P-trend 
< 0.01). Although cigarette smoking amount and cigarette smoking
duration are important determinants of bladder cancer, adjustment
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Table 1 Description of mean daily intake of vitamins, carotenoids and vitamin supplement use and distribution of potential
confounding factors, Netherlands Cohort Study (1986–1992) 
Cases (n = 569) Sub-cohort (n = 3123) 
Exposure variables Mean SD  Mean SD 
Retinol (mg/day) 0.59 0.33 0.54 0.31 
Vitamin C (mg/day) 97.0 44.1 103 43.0 
Vitamin E (mg/day) 13.9 6.27 13.4 6.24 
Folate (mg/day) 219 73.7 212 0.70 
α -carotene (mg/day) 0.66 0.48  0.70 0.58 
β -carotene (mg/day) 2.89 1.42  2.97 1.58 
Lycopene (mg/day) 1.14 1.94 1.19 1.74 
β -cryptoxanthin (mg/day) 0.15 0.20  0.18 0.17 
Lutein/zeaxanthin (mg/day) 2.54 1.23 2.52  1.11 
Number Percentage Number Percentage 
Use of supplements containing vitamin A (% yes) 30  5.27 226 7.24 
Use of supplements containing vitamin C (% yes) 48  8.44 325 10.41 
Use of supplements containing vitamin E (% yes) 28  4.92 204 6.53 
Potential confounding factors Mean  SD Mean SD 
Age (years) 62.7 4.07 61.4 4.22 
Total water consumption (1/day) 2.13 0.52 2.07  0.49 
Alcohol consumption (g/day) 18.2 18.2 13.3  14.9 
Coffee consumption (cups/day) 4.80 2.39 4.29  2.16 
Tea consumption (cups/day) 2.45 2.02 2.86  2.03 
Total vegetable consumption (g/day) 190 82.4  194 83.5 
Total fruit consumption (g/day) 151 200 177  117 
Cigarette smoking amount (cig/day)* 18.7 11.3  15.0 10.3 
Cigarette smoking duration (years)* 37.5 11.6  31.6 12.3 
Number Percentage Number Percentage 
Sex (% male) 491 86.3 1525 48.8 
Cigarette smoking status (% current) 255 44.8  875 28.0 
Cigarette smoking status (% never) 62 10.9  1147 37.7 
Family history of bladder cancer (% yes) 7 1.23  59 1.89 
High risk occupation (% yes)† 4 0.70 15 0.48 
*Among smokers; †ever exposed to dye, rubber, leather, and vehicle fumes.
Table 2 Incidence rate ratios and 95% confidence intervals for bladder cancer according to quintiles of intake of retinol, vitamins C and E, and folate,
Netherlands Cohort Study (1986–1992) 
Quintiles of intake 
Vitamins Cases 1 (low)*  2 3 4 5 (high)  P-trend 
Retinol 
Median intake (mg/day) 0.26 0.38 0.48  0.61 0.87 
RR (95% Cl)† 569 1.00 0.75 (0.54–1.06) 0.95 (0.69–1.30) 0.98 (0.72–1.33) 0.92 (0.68–1.26) 0.71 
RR (95% Cl)‡ 475 1.00 0.83 (0.56–1.24) 1.04 (0.72–1.51) 1.02 (0.71–1.46) 1.04 (0.72–1.48) 0.67 
Vitamin C§
Median intake (mg/day) 54.9 86.6 135 
RR (95% Cl)† 569 1.00 0.77 (0.61–0.98) 0.74 (0.58–0.95) < 0.01 
RR (95% Cl)‡ 475 1.00 0.87 (0.66–1.14) 0.81 (0.61–1.07) 0.08 
Vitamin E 
Median intake (mg/day) 6.59 9.27 12.2  15.8 21.7 
RR (95% Cl)† 569 1.00 0.99 (0.72–1.36) 1.08 (0.79–1.48) 1.05 (0.77–1.43) 0.88 (0.65–1.20) 0.46 
RR (95% Cl)‡ 475 1.00 1.10 (0.76–1.61) 1.28 (0.90–1.84) 1.11 (0.77–1.59) 0.98 (0.68–1.41) 0.10 
Folate 
Median intake (mg/day) 0.14 0.17 0.20  0.23 0.29 
RR (95% Cl)† 569 1.00 0.80 (0.58–1.10) 0.80 (0.59–1.08) 0.72 (0.53–0.98) 0.93 (0.70–1.25) 0.55 
RR (95% Cl)‡ 475 1.00 0.85 (0.59–1.23) 0.87 (0.62–1.24) 0.82 (0.58–1.17) 1.03 (0.73–1.44) 0.77 
*Reference category; †adjusted for age (years) and sex; ‡adjusted for age (years); sex, cigarette smoking amount (cig/day) and cigarette smoking duration
(years); §for vitamin C, quintiles 2 and 3 and quintiles 4 and 5 were combined. 
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(Table 2). Also, adjustment for other potential confounders did not
substantially change the risk estimates (data not shown). 
The intake of the carotenoids α -carotene,  β -carotene,
luteine/zeaxantine, and lycopene were not associated with bladder
cancer risk (Table 3). The intake of β -cryptoxanthin appeared to be
inversely associated with bladder cancer risk (p-trend < 0.01) with
corresponding age- and sex adjusted RRs per increasing quintiles
of intake of 1.00 (reference), 0.63 (CI: 0.48–0.83), 0.54 (CI:
0.40–0.72), 0.59 (CI: 0.44–0.80) and 0.71 (CI: 0.53–0.95), respec-
tively. Adjustment for cigarette smoking or other potential
confounders did not change the results substantially (Table 3). 
Since the intake of vitamin C and β -cryptoxanthin were corre-
lated (r = 0.69), and both vitamin C and β -cryptoxanthin were
inversely associated with bladder cancer risk (Tables 2 and 3) we
estimated the incidence rate ratios for both nutrients after adjust-
ment for each other in addition to age, sex, cigarette smoking
amount and cigarette smoking duration (Table 4). After adjustment
for β -cryptoxanthin intake, the inverse association for vitamin C
intake disappeared. However, the RRs for β -cryptoxanthin intake
did not change essentially after adjustment for vitamin C intake
(Table 4). 
We investigated potential effect modification of the association
between  β -cryptoxanthin and bladder cancer risk by cigarette
smoking amount and duration (Table 5). We found a statistically
significant interaction effect with smoking amount (P < 0.01) but
not with smoking duration (P = 0.10). The inverse association
between β -cryptoxanthin and bladder cancer risk was not found
among non-smokers and appeared to be limited to cigarette
smokers who smoked more than 15 cigarettes per day or who
smoked for more than 35 years (Table 5) 
The protective effect of β -cryptoxanthin intake was observed in
each stratum of tumour invasiveness or morphology of male tran-
sitional cell carcinomas of the bladder, although the association
was less pronounced for non-invasive papillary tumours 
(Table 6). 
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Table 3 Incidence rate ratios and 95% confidence intervals for bladder cancer according to quintiles of intake of carotenoids, Netherlands Cohort Study
(1986–1992) 
Quintiles of intake 
Carotenoids No. of cases 1 (low)*  2 3 4 5 (high)  P-trend 
α -Carotene 
Median intake (mg/day) 0.19 0.38 0.57  0.82 1.31 
RR (95% Cl)† 569 1.00 0.85 (0.63–1.13) 0.74 (0.55–1.00) 0.90 (0.68–1.20) 0.83 (0.61–1.11) 0.27 
RR (95% Cl)‡ 475 1.00 0.81 (0.58–1.13) 0.76 (0.54–1.06) 0.83 (0.60–1.16) 0.99 (0.71–1.39) 0.89 
β -Carotene 
Median intake (mg/day) 1.43 2.10 2.65  3.37 4.76 
RR (95% Cl)† 569 1.00 1.04 (0.77–1.39) 0.87 (0.64–1.18) 0.89 (0.66–1.20) 0.98 (0.73–1.32) 0.51 
RR (95% Cl)‡ 475 1.00 1.07 (0.77–1.49) 0.90 (0.63–1.27) 0.93 (0.66–1.32) 1.16 (0.82–1.63) 0.67 
Lutein and zeaxanthin 
Median intake (mg/day) 1.34 1.86 2.34  2.84 3.82 
RR (95% Cl)† 569 1.00 0.97 (0.72–1.31) 0.86 (0.64–1.16) 0.84 (0.62–1.13) 1.02 (0.76–1.37) 0.73 
RR (95% Cl)‡ 475 1.00 1.00 (0.71–1.41) 0.89 (0.63–1.26) 0.99 (0.70–1.40) 1.11 (0.79–1.57) 0.49 
β -cryptoxanthin 
Median intake (mg/day) 0.02 0.06 0.13  0.25 0.40 
RR (95% Cl)† 569 1.00 0.63 (0.48–0.83) 0.54 (0.40–0.72) 0.59 (0.44–0.80) 0.71 (0.53–0.95) < 0.01 
RR (95% Cl)‡ 475 1.00 0.70 (0.52–0.95) 0.56 (0.40–0.78) 0.62 (0.44–0.87) 0.74 (0.53–1.03) < 0.01 
Lycopene 
Median intake (mg/day) 0.15 0.48 0.81  1.21 2.21 
RR (95% Cl)† 569 1.00 0.83 (0.62–1.11) 1.07 (0.81–1.42) 1.05 (0.78–1.41) 0.97 (0.72–1.31) 0.58 
RR (95% Cl)‡ 475 1.00 0.85 (0.61–1.18) 1.07 (0.77–1.48) 1.18 (0.84–1.65) 1.08 (0.77–1.51) 0.16 
*Reference category; †adjusted for age (years) and sex; ‡adjusted for age (years), sex, cigarette smoking amount (cig/day) and cigarette smoking duration
(years).
Table 4 Incidence rate ratios and 95% confidence intervals for bladder cancer according to quintiles of vitamins C and β -cryptoxanthin adjusted for each other,
Netherlands Cohort Study (1986–1992) 
Quintiles of intake 
1 (low)*  2 3 4 5 (high)  P-trend 
Vitamin C†
RR (95% Cl)‡ 1.00 1.08 (0.80–1.46) 1.07 (0.73–1.57) 0.67 
β -cryptoxanthin 
RR (95% Cl)§ 1.00 0.69 (0.50–0.95) 0.54 (0.38–0.78) 0.60 (0.40–0.89) 0.71 (0.46–1.11) 0.01 
*Reference category; †for vitamin C, quintiles 2 and 3 and quintiles 4 and 5 were combined; ‡adjusted for age (years), sex, cigarette smoking amount (cig/day),
cigarette smoking duration (years) and β -cryptoxanthin intake; §adjusted for age (years), sex, cigarette smoking amount (cig/day), cigarette smoking duration
(years) and vitamin C intake. 
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ments containing vitamin A, vitamin C or Vitamin E were similar
to the risk for non-consumers. After adjustment for age, sex, ciga-
rette smoking amount and cigarette smoking duration the RRs
were 1.12 (CI: 0.71–1.78), 1.01 (CI: 0.69–1.48), and 1.05 (CI:
0.63–1.73), respectively (data not shown). 
DISCUSSION 
The results of the prospective Netherlands Cohort Study showed
that, in general, the intake of retinol, vitamin C, vitamin E, folate,
carotenoids, and the use of vitamin supplements are not associated
with bladder cancer risk. The initially inverse association with
vitamin C intake disappeared after controlling for β -cryptoxanthin
intake. Only β -cryptoxanthin intake appeared to be inversely asso-
ciated with bladder cancer risk, especially among heavy cigarette
smokers.
The NLCS was carried out in the general Dutch population of
men and women aged 55–69 years at baseline. After 6.3 years of
follow-up, 569 bladder cancer cases were detected which is
substantially more than any other prospective study that investi-
gated the association between these nutrients, and the risk of
bladder cancer. The prospective nature of a cohort study together
with completeness of follow-up, as has been achieved in this 
study, reduced the potential for selection bias to a minimum. Non-
differential misclassification of exposure, may have resulted in
underestimation of the strength of the association. However, the
results of the validation study showed that the questionnaire was
able to rank subjects adequately according to their intake of most
nutrients. In a reproducibility study, it was further demonstrated
that the single food frequency questionnaire measurement could
characterize dietary habits for a period of at least 5 years
(Goldbohm et al, 1995). Information bias is also largely avoided
because dietary habits were reported before bladder cancer was
diagnosed. A change in dietary habits of subjects with latent
bladder cancer at the time of completing the baseline questionnaire
is much less likely than in subjects with, e.g. gastrointestinal
cancer. Furthermore, repeating analyses after excluding cases
diagnosed in the first 1 or 2 years hardly affected our 
results. 
A potentially more realistic problem in evaluating the observed
inverse associations is residual confounding by cigarette smoking.
We modelled cigarette smoking habits such that they best
explained bladder cancer (Zeegers et al, 2000a). This resulted in a
model including number of years smoked and habitual number of
cigarettes smoked per day, both as continuous variables. We there-
fore believe that the associations observed were not entirely due to
residual confounding by smoking, although we cannot exclude
some influence. When we added the smoking variables to an age-
and sex-adjusted model, the RR estimates changed only slightly.
We were not able to explain our results on the basis of confounding
of other factors in addition to cigarette smoking, since our results
were essentially unchanged after incorporating into the analyses
many known or suspected risk factors for bladder cancer,
including total consumption of alcohol, coffee, tea, and water, high
risk occupation, and family history of bladder cancer. 
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Table 5 Incidence rate ratios and 95% confidence intervals for bladder cancer according to β -cryptoxanthin intake, with respect to cigarette smoking amount
and duration; Netherlands Cohort Study (1986–1992) 
Quintiles of β -cryptoxanthin intake
Cigarette smoking 1 (low)*  2 3 4 5 (high)  P-trend 
Never-smoker† 1.00 0.86 (0.35–2.13) 0.88 (0.37–2.09) 0.89 (0.38–2.08) 1.16 (0.51–2.64) 0.67 
Amount (cig/day)‡ 
< 15 1.00 0.83 (0.50–1.40) 0.59 (0.33–1.06) 0.98 (0.57–1.67) 1.34 (0.79–2.27) 0.25 
15+ 1.00 0.68 (0.47–1.00) 0.59 (0.39–0.88) 0.50 (0.32–0.78) 0.54 (0.35–0.83) < 0.01 
Duration (years)§ 
< 35 1.00 0.83 (0.49–1.39) 0.52 (0.29–0.94) 0.71 (0.40–1.26) 0.90 (0.52–1.54) 0.47 
35+ 1.00 0.67 (0.46–0.99) 0.61 (0.41–0.91) 0.60 (0.39–0.91) 0.67 (0.43–1.03) < 0.01 
*Reference category; †adjusted for age and sex; ‡adjusted for age (years), sex, and cigarette smoking duration (years); §adjusted for age (years), sex, and
cigarette smoking amount (cig/day).
Table 6 Incidence rate ratios and 95% confidence intervals for transitional cell carcinoma of the urinary bladder according to β -cryptoxanthin intake, with
respect to tumour invasiveness and morphology; Netherlands Cohort Study (1986–1992) 
Non-invasive (TIS/T s/T 1) Invasive (T2–4) 
β -cryptoxanthin Non-papillary (n = 24)* Papillary (n = 232)† Non-papillary (n = 111)* Papillary (n = 146)†
(quintiles of intake) RR (95% Cl)‡ RR (95% Cl)‡ RR (95% Cl)‡ RR (95% Cl)‡
1 (low) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 
2 0.38 (0.10–1.43) 1.03 (0.68–1.57) 0.66 (0.37–1.19) 0.51 (0.29–0.88) 
3 0.30 (0.06–1.42) 0.75 (0.47–1.20) 0.54 (0.28–1.02) 0.44 (0.24–0.79) 
4 0.51 (0.14–1.88) 0.82 (0.51–1.33) 0.55 (0.28–1.09) 0.49 (0.27–0.88) 
5 (high) 0.18 (0.02–1.57) 0.84 (0.52–1.36) 0.72 (0.38–1.36) 0.71 (0.41–1.23) 
P-value for linear trend 0.04 0.22 0.11 0.06 
ICD-O:M8120, †ICDO:M8130, ‡adjusted for age (years), sex, cigarette smoking amount (cig/day), and cigarette smoking duration (years). 
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differentiation is a feature of cancer cells, a protective effect of
vitamin A on cancer development may be expected (Kamat and
Lamm, 1999; Patterson et al, 1997; Steinmetz and Potter, 1991).
Retinol is the physiologically active form of vitamin A and 
can also be derived from some carotenoids (e.g. α -carotene, 
β -carotene, and β -cryptoxantine). Some carotenoids have antioxi-
dant properties and may inhibit carcinogenesis by preventing
DNA damage induced by free radicals. However, a recently
published meta-analysis based on seven case control studies and
three cohort studies did not find increased risks for diets low in
retinol or β -carotene (Steinmaus et al, 2000). A prospective study
that was published more recently also found no association
between supplemental and dietary vitamin A intake and bladder
cancer risk (Michaud et al, 2000). In the present study, only the
dietary intake of the carotenoid β -cryptoxanthin appeared to be
inversely associated with bladder cancer risk. We know of no
biological mechanism other than its provitamin A activity that
might explain this specific association. Citrus fruits are the main
sources of β -cryptoxanthin. In a previous analysis we also
presented an inverse association between citrus fruit consumption
and bladder cancer risk (Zeegers, submitted for publication).
However, an other previously conducted prospective study did not
find an association between β -cryptoxanthin and bladder cancer
risk (Michaud et al, 1999). Further research is needed to evaluate
this matter. 
Vitamin C is mostly known for its antioxidant capacity
(Steinmetz and Potter, 1991) and its ability to prevent formation of
nitrosamine and other N-nitroso compounds (Birt, 1986). In addi-
tion to β -cryptoxanthin, citrus fruits are also known for their high
content of vitamin C. After adjustment for β -cryptoxanthin, the
small inverse association between vitamin C intake and bladder
cancer risk increased towards unity. Two previously conducted
population based case-control studies found small increased risks
of bladder cancer with increasing intake of dietary vitamin C for
men and women combined (Risch et al, 1988) or for men only
(Nomura et al, 1991) after controlling for cigarette smoking.
However, other population based case control studies presented
decreased risks for men and women combined (Bruemmer et al,
1996) or for women only (Nomura et al, 1991), or found no asso-
ciation at all (Riboli et al, 1991). One prospective study suggested
an inverse association with dose of vitamin C supplement use, but
not with dietary vitamin C intake (Michaud et al, 2000), which is
in correspondence to the results of the present study. 
Like vitamin C, vitamin E is an intracellular antioxidant and can
inhibit nitrosation (Kamat and Lamm, 1999; Knekt et al, 1988;
Patterson et al, 1997). Two population based case control studies
(Bruemmer et al, 1996; Riboli et al, 1991) and one prospective
study (Michaud et al, 2000) reported inverse associations between
dietary vitamin E intake and bladder cancer risk. We did not find
statistically significant associations, although the point estimates
were moderately negative. 
Folate is essential for methylation reactions in the human body.
Reduced methylation of DNA may contribute to loss of normal
controls on proto-oncogene expression. Folate deficiency causes
massive incorporation of uracil into human DNA and chromosome
breaks. Such breaks could contribute to an increased risk of cancer
(Blount et al, 1997; Glynn and Albanes, 1994). The epidemiologic
evidence relating dietary folate and the risk of bladder cancer is
limited. One previously conducted case-control study found a
moderately inverse association between folate intake and bladder
cancer risk (Bruemmer et al, 1996), whereas a recently published
prospective study did not find an association with bladder cancer
risk (Michaud et al, 2000). In the present study, we found no asso-
ciation between folate intake and bladder cancer risk. 
We conclude that dietary or supplemental intake of vitamin A,
vitamin C, vitamin E, and dietary intake from folate and
carotenoids are not associated with bladder cancer risk. Only β -
cryptoxanthin appeared to be inversely associated and this
deserves further scientific attention. 
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